Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection

Richard K Sterling1, Mark S Sulkowski

  • 1Virginia Commonwealth University Health System/Medical College of Virginia, Richmond, Virginia 23298, USA. rksterli@hsc.vcu.edu

Seminars in Liver Disease
|September 4, 2004
PubMed

Insights

Coinfection with hepatitis C virus (HCV) or hepatitis B virus (HBV) is common in HIV patients. Managing HCV/HBV coinfection in HIV requires specific treatment strategies to prevent severe liver disease and hepatocellular carcinoma.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Coinfection with hepatitis C virus (HCV) or hepatitis B virus (HBV) is prevalent in HIV-infected individuals due to shared transmission routes.
  • Improved life expectancy in HIV patients due to antiretroviral therapy has made HCV-related liver disease a significant comorbidity.
  • HIV coinfection can exacerbate HCV progression, leading to increased liver disease severity, fibrosis, and hepatocellular carcinoma (HCC) risk.

Purpose of the Study:

  • To summarize the impact of HCV and HBV coinfection on HIV-infected individuals.
  • To review current treatment recommendations for chronic HCV in HIV-coinfected patients.
  • To discuss the undefined optimal treatment for chronic HCV in patients coinfected with HBV.

Main Methods:

  • Literature review of studies on HIV, HCV, and HBV coinfection.
  • Analysis of current clinical guidelines for managing coinfections.
  • Synthesis of data on disease progression and treatment outcomes.

Main Results:

  • HIV coinfection is associated with higher HCV RNA levels and accelerated liver fibrosis.
  • Coinfection with HCV and HBV can lead to more severe liver disease and a greater risk of HCC compared to HCV alone.
  • Pegylated interferon alfa plus ribavirin is recommended for treating chronic HCV in eligible HIV-infected persons.

Conclusions:

  • HCV and HBV coinfection significantly impacts liver disease progression in HIV patients.
  • Treatment for chronic HCV in HIV-coinfected individuals is guided by current recommendations.
  • Optimal treatment strategies for chronic HCV in patients coinfected with HBV require further definition, potentially including interferon-based therapies and additional antivirals.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...